Background An established pharmaceutical company with a strong background in biologics and biosimilars was preparing to enter Phase 3 clinical…
Background A pharmaceutical company preparing for product commercialization faced significant challenges in meeting FDA expectations. The organization lacked standard operating…
Background A life sciences company preparing for growth and regulatory scrutiny faced major deficiencies in its quality infrastructure. The organization…